SEARCH

SEARCH BY CITATION

References

  • Brown, J. & Bosak, J. (1986) An ELISA test for the binding of vonWillebrand antigen to collagen. Thrombosis Research, 43, 303311.
  • Favaloro, E.J. (2000) Collagen binding assay for von Willebrand factor: detection of von Willebrand's disease and discrimination of VWD subtypes depends on collagen source. Thrombosis and Haemostasis, 83, 127135.
  • Favaloro, E. & Koutts, J. (1997) Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology, 29, 385390.
  • Favaloro, E., Grispo, T., Exner, T. & Koutts, J. (1990) Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and type II von Willebrand disease. Blood Coagulation and Fibrinolysis, 2, 285291.
  • Favaloro, E., Grispo, L., Dinale, A., Berndt, M. & Koutts, J. (1993) vonWillebrand disease: laboratory investigation using an improved functional assay for von Willebrand factor. Pathology, 25, 152158.
  • Favaloro, E., Smith, J., Petinos, P., Hertzberg, M. & Koutts, J. (1999) Laboratory testing for von Willebrand's disease: an assessment ofcurrent diagnostic practice and efficacy by means of a multi-laboratory survey. Thrombosis and Haemostasis, 82, 12761282.
  • Favaloro, E., Henniker, A., Facey, D. & Hertzberg, M. (2000) Discrimination of von Willebrand's disease (VWD) subtypes: direct comparison of von Willebrand factor: collagen binding assay (VWF:CBA) with monoclonal antibody (MAB)-based VWF-capture systems. Thrombosis and Haemostasis, 84, 541547.
  • Federici, A. (1998) Diagnosis of von Willebrand's disease. Haemophilia, 4, 654–660.
  • Federici, A.B., Canciani, M.T., Forza, I. & Cozzi, G. (2000) Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease. Thrombosis and Haemostasis, 84, 11271128.
  • Fischer, B.E., Thomas, K.B. & Dorner, F. (1998) Von Willebrand factor: measuring antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems. Thrombosis and Haemostasis, 91, 3943.
  • Gardner, M. & Altman, D.G. (1989) Statistics with Confidence. British Medical Journal Books, pp. 7179. University Press, Belfast.
  • Hilbert, L., Jenkins, P.V., Gaucher, C., Meriane, E., Collins, P.W., Pasi, K.J. & Mazurier, C. (2000) Type 2M VWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of Von Willebrand factor. Thrombosis and Haemostasis, 84, 188194.
  • Hillery, C.A., Mancuso, D.J., Sadler, J., Ponder, J.W., Jozwiak, M.A., Christopherson, P.A., Cox Gill, J., Scott, J. & Montgomery, R.R. (1998) Type 2M von Willebrand disease: F6061 and 166F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin- mediated binding of von Willebrand factor to platelets. Blood, 91, 15721581.
  • McFarlane, D.E., Stibbe, J., Kibbey, E.P., Zucher, M.B., Grant, R. & McPherson, J. (1975) A method for assaying vonWillebrandfactor (ristocetin co-factor). Thrombosis and Diathesis Haemorrhagica, 34, 306308.
  • Mancuso, D.J., Kroner, P., Christopherson, P., Vokac, E., GillJ.C. & Montgomery, R. (1996) Type 2M: Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509–Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets. Blood, 88, 2559.
  • Mazurier, C., Gaucher, C., Jorieux, S. & Parquet-Gerne, A. (1990) Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling. British Journal of Haematology., 76, 372379.
  • Nitu-Whalley, I., Riddell, A., Lee, C.A., Pasi, K.J., Owens, D., Enayat, M.S., Perkins, S.J. & Jenkins, P.V. (2000) Identification of type 2 von Willebrand's disease in previously diagnosed type 1 patients: a reappraisal using, phenotypes, genotypes and molecular modelling. Thrombosis and Haemostasis, 84, 9981004.
  • Sadler, J.E. (1994) A revised classification of von Willebrand disease. For the subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis and Haemostasis, 71, 520525.
  • Sadler, J.E. (1998) Biochemistry and genetics of von Willebrand factor. Annual Reviews of Biochemistry, 67, 395424.
  • Woodhams, B.J. & Kernoff, P.B.A. (1983) The application of polyethylene glycol to radioimmunoassays used in haemostasis. Thrombosis Research, 29, 333341.
  • Vanhoorelbeke, K., Cauwenberghs, N., Vauterin, S., Schlammadinger, A., Mazurier, C. & Deckmyn, C. (2000) A reliable and reproducible ELISA method to measure ristocetin cofactor activity ofvon Willebrand factor. Thrombosis and Haemostasis, 83, 107113.